-
11:10:43 AM

BLCO Stock News

02/15/23 6:58 AM
NYSE : BLCO
management
Bausch + Lomb Appoints Brent Saunders as Chief Executive Officer and Chair of the Board of Directors, Effective March 6, 2023
Bausch+ Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, announced the appointment of Brent Saunders as chief executive officer and chair of the Board of Directors of the Company, effective March 6, 2023. To facilitate an orderly transition, Mr. Saunders will join Bausch+ Lomb on Feb. 16, 2023, in an...
RHEA-AI
very positive
02/01/23 7:00 AM
NYSE : BLCO
fda approval
Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection)
Bausch+ Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, and Modulight Corporation, a biomedical laser company, today announced that the U.S. Food and Drug Administration has approved the ML6710i photodynamic laser for equivalent use with Bausch+ Lomb’ s VISUDYNE ®...
RHEA-AI
positive
01/09/23 8:00 AM
NYSE : BLCO
Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™
Bausch+ Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision ® AREDS 2 Formula mini soft gels with OCUSorb™. “For my patients with moderate to advanced Age-related Macular Degeneration, a leading cause of vision loss in Americans ages 50 and older, I...
RHEA-AI
positive
01/09/23 7:00 AM
NYSE : BLCO
Bausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference
Bausch+ Lomb Corporation,, a leading global eye health company dedicated to helping people see better to live better, has published a company update presentation designed to complement remarks that will be provided by management at 3:00 p.m. PT today, Jan. 9, 2023, during the 41 st Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is...
RHEA-AI
neutral
01/05/23 7:00 AM
NYSE : BLCO
Bausch + Lomb Announces Participation at the 41st Annual J.P. Morgan Healthcare Conference
Bausch+ Lomb Corporation,, a leading global eye health company dedicated to helping people see better to live better, today announced that Joseph C. Papa, chief executive officer, and Sam Eldessouky, executive vice president and chief financial officer, are scheduled to participate at the 41 st Annual J.P. Morgan Healthcare Conference on Jan. 9, 2023, at 3:00 p.m....
RHEA-AI
neutral